Kronos Bio (KRON)
(Delayed Data from NSDQ)
$0.99 USD
-0.01 (-1.40%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $0.98 -0.01 (-0.52%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for Kronos Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -112.67 | -133.20 | -151.08 | -88.44 | -16.12 |
Depreciation/Amortization & Depletion | -0.29 | 1.73 | 5.97 | 1.17 | 0.35 |
Net Change from Assets/Liabilities | 5.88 | 6.18 | -1.62 | 6.46 | 0.28 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 28.50 | 34.37 | 28.80 | 42.91 | 0.41 |
Net Cash From Operating Activities | -78.58 | -90.93 | -117.92 | -37.91 | -15.08 |
Property & Equipment | -0.68 | -0.58 | -4.26 | -9.57 | -2.95 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 67.05 | -31.64 | 67.98 | -150.67 | -64.63 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 66.37 | -32.22 | 63.72 | -160.24 | -67.58 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.57 | 0.85 | 4.47 | 264.37 | 105.04 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -0.01 | 151.24 | -0.03 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.57 | 0.85 | 4.46 | 415.61 | 105.01 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -11.65 | -122.30 | -49.74 | 217.47 | 22.34 |
Cash at Beginning of Period | 78.00 | 200.30 | 250.04 | 32.57 | 10.23 |
Cash at End of Period | 66.35 | 78.00 | 200.30 | 250.04 | 32.57 |
Diluted Net EPS | -1.95 | -2.37 | -2.76 | -5.43 | NA |
Fiscal Year End for Kronos Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -46.16 | -29.96 | -112.67 | -87.35 | -55.98 |
Depreciation/Amortization & Depletion | -1.03 | -0.63 | -0.29 | -2.45 | -1.59 |
Net Change from Assets/Liabilities | -11.89 | -8.59 | 5.88 | 11.17 | 8.57 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 18.84 | 15.28 | 28.50 | 25.07 | 18.02 |
Net Cash From Operating Activities | -40.23 | -23.90 | -78.58 | -53.56 | -30.97 |
Property & Equipment | -0.01 | -0.01 | -0.68 | -0.65 | -0.43 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 45.95 | 5.78 | 67.05 | 35.46 | -0.55 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 45.95 | 5.77 | 66.37 | 34.81 | -0.98 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.16 | 0.00 | 0.57 | 0.38 | 0.38 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.16 | 0.00 | 0.57 | 0.38 | 0.38 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 5.88 | -18.13 | -11.65 | -18.37 | -31.58 |
Cash at Beginning of Period | 66.35 | 66.35 | 78.00 | 78.00 | 78.00 |
Cash at End of Period | 72.23 | 48.22 | 66.35 | 59.63 | 46.42 |
Diluted Net EPS | -0.27 | -0.50 | -0.43 | -0.54 | -0.52 |